Skip to content
Checked.be
Complete company report
Generated 27-08-2026
Active BE 0400.778.165Public limited company

PFIZER MANUFACTURING BELGIUM

Rijksweg 12 ·2870 Puurs-Sint-Amands, Belgium· 65 yrs active
Sector: Vervaardiging van geneesmiddelen (21201)
Conclusion Checked

The computed 12-month bankruptcy probability of PFIZER MANUFACTURING BELGIUM is 0.7% (low). The company has been active since 1960 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 65 yrs
Board 3
Locations 6
Publications 23
Bankruptcy probability (12 mo) Checked model v1 · free
0.7% Low
0%0,5%1,5%4%10%≥25%
Multiple establishment units +Long track record −Lower-risk legal form −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 2 signals
Long-established
Founded in 1960, 66 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags0 events
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financial overview10 NBB filings
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2025 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
30-11-2025 volledig 02-06-2026 2026-00135210
30-11-2024 volledig 26-05-2025 2025-00107871
30-11-2023 volledig 27-05-2024 2024-00098659
30-11-2022 volledig 30-05-2023 2023-00107558
31-12-2021 consolidatie 09-06-2022 2022-20056782
30-11-2021 volledig 03-06-2022 2022-20050230
31-12-2020 consolidatie 14-06-2021 2021-20300034
30-11-2020 volledig 14-06-2021 2021-20200573
31-12-2019 consolidatie 03-06-2020 2020-14500387
30-11-2019 volledig 28-05-2020 2020-13400211
Directors & mandates 26 directors
Directors derived from a single State Gazette act, under verification
All 3 current directors first appear in the same act (24111891). Founders or capital subscribers may have been counted as directors here; the real board composition is being verified.
Current directors & mandates
  • J. Beumer
    Director
    State Gazette act 24111891 (24-07-2024)
    Current
    02-07-2018 → present
    3 events
    • 24-07-2024 Appointed· Director
    • 22-06-2022 Appointed· Director
    • 02-07-2018 Appointed· Director
  • L. Van Steenwinkel
    Director
    State Gazette act 24111891 (24-07-2024)
    Current
    02-07-2018 → present
    3 events
    • 24-07-2024 Appointed· Director
    • 22-06-2022 Appointed· Director
    • 02-07-2018 Appointed· Director
  • Monique Slootmaeckers
    Director
    State Gazette act 24111891 (24-07-2024)
    Current
    02-07-2018 → present
    3 events
    • 24-07-2024 Appointed· Director
    • 22-06-2022 Appointed· Director
    • 02-07-2018 Appointed· Director
Historic, not recently confirmed (12)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
  • Steven Veyt
    Auditor
    State Gazette act 18165566 (16-11-2018)
    Not recently confirmed
    last confirmed in an act from 2018
  • Oliver Declercg
    Auditor
    State Gazette act 17158623 (10-11-2017)
    Not recently confirmed
    last confirmed in an act from 2017
  • Sofie Depuydt
    Volmachtdrager / vertegenwoordiger
    State Gazette act 16092669 (05-07-2016)
    Not recently confirmed
    last confirmed in an act from 2016
  • Luc Van Steenwinkel
    Director
    State Gazette act 11088893 (15-06-2011)
    Not recently confirmed
    last confirmed in an act from 2011
    2 events
    • 15-06-2011 Appointed· Director
    • 15-06-2011 Appointed· Managing director
  • P. Duffy
    Director
    State Gazette act 11015618 (28-01-2011)
    Not recently confirmed
    last confirmed in an act from 2011
    2 events
    • 28-01-2011 Appointed· Director
    • 28-01-2011 Appointed· Voorzitter van de raad van bestuur
  • Karl Aymanns
    Director
    State Gazette act 03132696 (15-12-2003)
    Not recently confirmed
    last confirmed in an act from 2003
  • W. Van Effeltaire
    Director
    State Gazette act 03132696 (15-12-2003)
    Not recently confirmed
    last confirmed in an act from 2003
  • Christian De Waen
    Director
    State Gazette act 03067969 (19-06-2003)
    Not recently confirmed
    last confirmed in an act from 2003
  • Damır Rapic
    Director
    State Gazette act 03067969 (19-06-2003)
    Not recently confirmed
    last confirmed in an act from 2003
  • Etienne Catthoor
    Director
    State Gazette act 03067969 (19-06-2003)
    Not recently confirmed
    last confirmed in an act from 2003
  • Philippe De Backer
    Director
    State Gazette act 03067969 (19-06-2003)
    Not recently confirmed
    last confirmed in an act from 2003
  • Özer Baysal
    Director
    State Gazette act 03067969 (19-06-2003)
    Not recently confirmed
    last confirmed in an act from 2003
Former directors (11)
  • Olivier Declercq
    Auditor
    State Gazette act 18165566 (16-11-2018)
    Former
    - → 16-11-2018
  • Patrick Simons
    Auditor
    State Gazette act 17158623 (10-11-2017)
    Former
    - → 10-11-2017
  • Dirk Verbestel
    Director
    State Gazette act 17127429 (06-09-2017)
    Former
    - → 06-09-2017
  • J. Deneve
    Afgevaardigd bestuurder
    State Gazette act 03132696 (15-12-2003)
    Former
    15-12-2003 → 15-06-2011
    2 events
    • 15-06-2011 Resigned· Director
    • 15-12-2003 Appointed· Afgevaardigd bestuurder
  • P. Ginestet
    Voorzitter van de raad van bestuur
    State Gazette act 11015618 (28-01-2011)
    Former
    - → 28-01-2011
6 further former directors in the mandate history. Available in Kantoor S. See plans →
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.
Statutory auditor 3 auditor
Statutory auditor IRE/IBR number Tenure
CVBA KPMG Bedrijfsrevisoren BVCurrent
Statutory auditor
 - 24-07-2024 → present
Show 2 earlier auditors
KPMG Bedrijfsrevisoren
Statutory auditor
succeeded by KPMG Bedrijfsrevisoren BV in 2022
 - 02-07-2018 → 22-06-2022
KPMG Bedrijfsrevisoren BV
Statutory auditor
succeeded by CVBA KPMG Bedrijfsrevisoren BV in 2024
 - 22-06-2022 → 24-07-2024
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
NACE primary Vervaardiging van geneesmiddelen(21201)
Legal form Public limited company(014)
Incorporation09-09-1960
StatusActive
Postal code2870
Establishment units 6 locations
PFIZER manufacturing Belgium NV
Rijksweg 12, 2870 Puurs-Sint-Amandsde vervaardiging van salicylzuur en o-acetylsalicylzuur
since 19602.006.278.417
PFIZER MANUFACTURING BELGIUM NV
Rijksweg 6, 2870 Puurs-Sint-AmandsVervaardiging van farmaceutische grondstoffen
since 20172.261.678.724
PFIZER MANUFACTURING BELGIUM NV
Rijksweg 20, 2870 Puurs-Sint-AmandsVervaardiging van farmaceutische grondstoffen
since 20172.261.678.823
PFIZER MANUFACTURING BELGIUM NV
Rijksweg 8, 2870 Puurs-Sint-AmandsVervaardiging van farmaceutische grondstoffen
since 20172.261.678.922
PFIZER MANUFACTURING BELGIUM NV
Rijksweg 10, 2870 Puurs-Sint-AmandsVervaardiging van farmaceutische grondstoffen
since 20232.341.753.907
PFIZER MANUFACTURING BELGIUM
Schoonmansveld 28, 2870 Puurs-Sint-AmandsVerkoop aan de toog of via telefoon, fax, internet van eetwaren en dranken : cafetaria's
since 20232.345.938.268
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 5 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
12030D0050/00F000 Flanders 11.5 ha 1 · 7.0 ha -
12008A0021/00M000 Flanders 8.0 ha 1 · 3.0 ha -
12030D0035/00S000 Flanders 3.9 ha 1 · 1.3 ha 11.1 m · 3 fl.
12032C0431/00C000 Flanders 3.0 ha 1 · 1.3 ha 13.9 m · 4 fl.
12030D0036/00S000 Flanders 9,712 m² 1 · 3,056 m² 10.3 m · 3 fl.
Methodology
via registered seat: 1 · via establishment units: 4
5 of 5 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 33 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
02-06-2026
NBB filing Annual accounts filed
fiscal year 2025 · volledig
2025
26-05-2025
NBB filing Annual accounts filed
fiscal year 2024 · volledig
2024
24-07-2024
State Gazette act Director changes
v3.2
24-07-2024
State Gazette act Director changes
v3.2
27-05-2024
NBB filing Annual accounts filed
fiscal year 2023 · volledig
2023
09-06-2023
State Gazette act Miscellaneous
other · Imane Nassah
30-05-2023
NBB filing Annual accounts filed
fiscal year 2022 · volledig
2022
22-06-2022
State Gazette act Director changes
v3.2
09-06-2022
NBB filing Annual accounts filed
fiscal year 2021 · consolidatie
03-06-2022
NBB filing Annual accounts filed
fiscal year 2021 · volledig
2021
20-12-2021
State Gazette act Miscellaneous
completed · Peter VAN MELKEBEKE
22-10-2021
State Gazette act Miscellaneous
proposal · Charlotte Peeters
14-06-2021
NBB filing Annual accounts filed
fiscal year 2020 · consolidatie
14-06-2021
NBB filing Annual accounts filed
fiscal year 2020 · volledig
09-02-2021
State Gazette act Miscellaneous
Intent announcement · Frederik Verhaeghe
2020
14-12-2020
State Gazette act Capital & shares
v3.2
05-11-2020
State Gazette act Miscellaneous
proposal · Frederik Verhaeghe
27-10-2020
State Gazette act Capital & shares
v3.2
03-06-2020
NBB filing Annual accounts filed
fiscal year 2019 · consolidatie
28-05-2020
NBB filing Annual accounts filed
fiscal year 2019 · volledig
2018
16-11-2018
State Gazette act Director changes
v3.2
16-11-2018
State Gazette act Director changes
v3.2
02-07-2018
State Gazette act Director changes
v3.2
02-07-2018
State Gazette act Director changes
v3.2
28-02-2018
State Gazette act Director changes
v3.2
2017
10-11-2017
State Gazette act Director changes
v3.2
10-11-2017
State Gazette act Director changes
v3.2
06-09-2017
State Gazette act Director changes
v3.2
2016
05-07-2016
State Gazette act Director changes
v3.2
2011
15-06-2011
State Gazette act Director changes
v3.2
28-01-2011
State Gazette act Director changes
v3.2
2003
15-12-2003
State Gazette act Director changes
v3.2
19-06-2003
State Gazette act Statutes amendment
v3.2
Belgian State Gazette reading coverage 0 of 46 acts read

We know of 46 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Belgisch Staatsblad, acts 23 acts
Capital history · 2
14-12-2020
v3.2
27-10-2020
v3.2
All acts · 23 updated 2 years ago
2024
24-07-2024 CVBA KPMG Bedrijfsrevisoren BV appointed as statutory auditor Director changes
  • CVBA KPMG Bedrijfsrevisoren BV, Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "CVBA KPMG Bedrijfsrevisoren BV",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium NV"
  }
}
24-07-2024 3 directors appointed Director changes
  • L. Van Steenwinkel, Bestuurder
  • J. Beumer, Bestuurder
  • Monique Slootmaeckers, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "L. Van Steenwinkel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "J. Beumer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Monique Slootmaeckers",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}
2023
09-06-2023 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Imane Nassah
Summary: otherNotary: Imane Nassah · Antwerpen
Technical details 
{
  "stage": null,
  "notary": {
    "name": "Imane Nassah",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": null,
    "filing_date": "2023-05-30",
    "act_kind_objet": "2870 Puurs-Sint-Amands"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2023-05-05",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0400.778.165",
        "name": "PFIZER MANUFACTURING BELGIUM",
        "role": "other",
        "address": "Rijksweg 12, 2870 Puurs-Sint-Amands",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "Geen overdracht van patrimoine; enkel wijziging van de woonplaats van bestuurders.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "PFIZER MANUFACTURING BELGIUM",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Imane Nassah",
    "org_rep_person_name": null
  },
  "summary_narrative": "De raad van bestuur van Pfizer Manufacturing Belgium besliste unaniem op 5 mei 2023 de woonplaats van de bestuurders te wijzigen, met ingang vanaf die datum. De bestuurders Jan Beumer, Luc Van Steenwinkel en Monique Slootmaeckers kiezen hun woonplaats op de zetel van de vennootschap. Daarnaast verleenden de bestuurders bijzondere machten aan advocaten van DLA Piper UK LLP om de publicatie van deze besluiten in het Belgisch Staatsblad te verwezenlijken.",
  "co_filed_documents": [],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "director_changes"
}
2022
22-06-2022 4 directors appointed Director changes
  • KPMG Bedrijfsrevisoren BV, Commissaris
  • L. Van Steenwinkel, Bestuurder
  • J. Beumer, Bestuurder
  • Monique Slootmaeckers, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "KPMG Bedrijfsrevisoren BV",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "L. Van Steenwinkel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "J. Beumer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Monique Slootmaeckers",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "PFIZER MANUFACTURING BELGIUM"
  }
}
2021
20-12-2021 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Peter VAN MELKEBEKE
Summary: completedNotary: Peter VAN MELKEBEKE · BrusselFirm: BERQUIN NOTARISSEN
Technical details 
{
  "stage": "completed",
  "notary": {
    "name": "Peter VAN MELKEBEKE",
    "firm_city": null,
    "firm_name": "BERQUIN NOTARISSEN",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2021-12-20",
    "filing_date": "2021-10-15",
    "act_kind_objet": "VERRICHTING GELIJKGESTELD MET EEN FUSIE DOOR OVERNEMING"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2021-11-30",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0400.778.165",
        "name": "Pfizer Manufacturing Belgium",
        "role": "acquiring",
        "address": "2870 Puurs-Sint-Amands, Rijksweg 12",
        "is_foreign": false,
        "legal_form": "naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Pfizer Financial Services BV",
        "role": "absorbed",
        "address": "2870 Puurs-Sint-Amands, Rijksweg 12",
        "is_foreign": false,
        "legal_form": "besloten vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:50",
      "2:8",
      "2:14"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Het gehele vermogen van de Overgenomen Vennootschap wordt zonder uitzondering of voorbehoud overgenomen onder algemene titel door de Overnemende Vennootschap.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2021-11-30"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium",
    "legal_form": "naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Peter VAN MELKEBEKE",
    "org_rep_person_name": null
  },
  "summary_narrative": "De buitengewone algemene vergadering van Pfizer Manufacturing Belgium, naamloze vennootschap met zetel te Puurs-Sint-Amands, heeft op 30 november 2021 besloten tot de overname van Pfizer Financial Services BV, ook gevestigd te Puurs-Sint-Amands, in het kader van een verrichting gelijkgesteld met een fusie door overneming. De overname treedt juridisch en boekhoudkundig in werking op 30 november 2021, om 24.00 uur. Het gehele vermogen van de overgenomen vennootschap gaat onder algemene titel over op de overnemende vennootschap.",
  "co_filed_documents": [
    "uitgifte van het proces-verbaal",
    "twee volmachten"
  ],
  "detected_real_type": "fusion_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
22-10-2021 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Charlotte Peeters
Summary: proposalNotary: Charlotte Peeters · Antwerpen
Technical details 
{
  "stage": "proposal",
  "notary": {
    "name": "Charlotte Peeters",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2021-10-22",
    "filing_date": "2021-10-11",
    "act_kind_objet": "Neerlegging fusievoorstel"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2021-10-11",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0429.712.968",
        "name": "Pfizer Financial Services",
        "role": "absorbed",
        "address": "Rijksweg 12, 2870 Puurs-Sint-Amands",
        "is_foreign": false,
        "legal_form": "besloten vennootschap",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0400.778.165",
        "name": "Pfizer Manufacturing Belgium NV",
        "role": "acquiring",
        "address": "Rijksweg 12, 2870 Puurs-Sint-Amands",
        "is_foreign": false,
        "legal_form": "naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:50",
      "12:7"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Het gehele vermogen, inclusief rechten en verplichtingen, van Pfizer Financial Services wordt overgenomen door Pfizer Manufacturing Belgium zonder liquidatie. De overname is gebaseerd op de volledige eigendom van alle aandelen van Pfizer Financial Services door Pfizer Manufacturing Belgium.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2021-11-30"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "PFIZER MANUFACTURING BELGIUM",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Charlotte Peeters",
    "org_rep_person_name": null
  },
  "summary_narrative": "Het bestuursorgaan van Pfizer Financial Services BV en Pfizer Manufacturing Belgium NV heeft een fusievoorstel ingediend overeenkomstig artikel 12:50 van het Wetboek van Vennootschappen en Verenigingen, met als doel een vereenvoudigde fusie door overname. Pfizer Manufacturing Belgium NV zal het gehele vermogen van Pfizer Financial Services BV overnemen zonder liquidatie, aangezien Pfizer Manufacturing Belgium al alle aandelen van de overgenomen vennootschap bezit. De fusie is gepland op basis van boekhoudkundige retroactiviteit vanaf 30 november 2021.",
  "co_filed_documents": [
    "fusievoorstel overeenkomstig artikel 12:50 van het Wetboek van vennootschappen en verenigingen met het oog op de met fusie door overneming gelijkgestelde verrichting tussen de naamloze vennootschap Pfizer Manufacturing Belgium en de besloten vennootschap Pfizer Financial Services"
  ],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
09-02-2021 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Frederik Verhaeghe
Summary: Intent announcementNotary: Frederik Verhaeghe · Antwerpen
Technical details 
{
  "stage": null,
  "notary": {
    "name": "Frederik Verhaeghe",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2021-02-09",
    "filing_date": "2021-02-02",
    "act_kind_objet": "Intrekken fusievoorstel"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2020-12-08",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "intent_announcement",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0400.778.165",
        "name": "PFIZER MANUFACTURING BELGIUM",
        "role": "other",
        "address": "Rijksweg 12, 2870 Puurs-Sint-Amands",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Pfizer Financial Services BV",
        "role": "other",
        "address": null,
        "is_foreign": true,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "NL"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50"
    ],
    "is_cross_border": true,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Het fusievoorstel met Pfizer Financial Services BV, een Nederlandse naamloze vennootschap, wordt ingetrokken. Geen overdracht van patrimoine vindt plaats.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "PFIZER MANUFACTURING BELGIUM",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Frederik Verhaeghe",
    "org_rep_person_name": null
  },
  "summary_narrative": "De raad van bestuur van Pfizer Manufacturing Belgium besloot, met eenparigheid van stemmen, op 8 december 2020 het fusievoorstel met Pfizer Financial Services BV in te trekken, dat eerder op 16 oktober 2020 was neergelegd. De beslissing werd genomen in het kader van Project LER, waarbij de fusie niet uitgevoerd zal worden. De raad verleende bijzondere machten aan advocaten van DLA Piper UK LLP om de publicatie van het intrekken van het fusievoorstel in het Belgisch Staatsblad te regelen.",
  "co_filed_documents": [],
  "detected_real_type": "intent_announcement",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
2020
14-12-2020 Capital decrease of €300,000,000 to €64,622,074 Capital & shares
  • €364.622.074 → €64.622.074
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 64622074.0,
      "delta_eur": -300000000.0,
      "before_eur": 364622074.0,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "PFIZER MANUFACTURING BELGIUM"
  }
}
05-11-2020 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Frederik Verhaeghe
Summary: proposalNotary: Frederik Verhaeghe · Antwerpen
Technical details 
{
  "stage": "proposal",
  "notary": {
    "name": "Frederik Verhaeghe",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2020-11-05",
    "filing_date": "2020-10-16",
    "act_kind_objet": "Neerlegging fusievoorstel"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2020-10-15",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0429.712.968",
        "name": "Pfizer Financial Services",
        "role": "absorbed",
        "address": "Rijksweg 12, 2870 Puurs-Sint-Amands",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0400.778.165",
        "name": "Pfizer Manufacturing Belgium",
        "role": "acquiring",
        "address": "Rijksweg 12, 2870 Puurs-Sint-Amands",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Het gehele vermogen, inclusief rechten en verplichtingen, van Pfizer Financial Services wordt overgenomen door Pfizer Manufacturing Belgium. De overname is gebaseerd op de volledige concentratie van aandelen van Pfizer Financial Services in handen van Pfizer Manufacturing Belgium.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2020-11-30"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Frederik Verhaeghe",
    "org_rep_person_name": null
  },
  "summary_narrative": "Het bestuursorgaan van Pfizer Financial Services NV en Pfizer Manufacturing Belgium NV heeft een fusievoorstel ingediend overeenkomstig artikel 12:50 van het Wetboek van Vennootschappen en Verenigingen, met als doel een vereenvoudigde fusie door overneming. Pfizer Manufacturing Belgium zal Pfizer Financial Services overnemen zonder liquidatie, aangezien Pfizer Manufacturing Belgium al alle aandelen van Pfizer Financial Services bezit. De fusie wordt boekhoudkundig geacht te zijn uitgevoerd vanaf 30 november 2020.",
  "co_filed_documents": [
    "fusievoorstel overeenkomstig artikel 12:50 van het Wetboek van vennootschappen en verenigingen met het oog op de met fusie door overneming gelijkgestelde verrichting tussen de naamloze vennootschap Pfizer Manufacturing Belgium en de naamloze vennootschap Pfizer Financial Services"
  ],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
27-10-2020 Capital increase of €29,595,340.62 to €314,642,069.55 Capital & shares
  • €285.046.728,93 → €314.642.069,55
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 314642069.55,
      "delta_eur": 29595340.620000005,
      "before_eur": 285046728.93,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "PFIZER MANUFACTURING BELGIUM"
  }
}
2018
16-11-2018 1 director appointed, 1 resigning Director changes
  • Steven Veyt, Auditor
  • Olivier Declercq, Auditor
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Olivier Declercq",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Steven Veyt",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}
16-11-2018 Change in the board of directors Director changes
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}
02-07-2018 KPMG Bedrijfsrevisoren appointed as statutory auditor Director changes
  • KPMG Bedrijfsrevisoren, Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "KPMG Bedrijfsrevisoren",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium NV"
  }
}
02-07-2018 3 directors appointed Director changes
  • L. Van Steenwinkel, Bestuurder
  • J. Beumer, Bestuurder
  • Monique Slootmaeckers, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "L. Van Steenwinkel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "J. Beumer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Monique Slootmaeckers",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}
28-02-2018 Change in the board of directors Director changes
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}
2017
10-11-2017 1 director appointed, 1 resigning Director changes
  • Oliver Declercg, Auditor
  • Patrick Simons, Auditor
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Patrick Simons",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Oliver Declercg",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}
10-11-2017 Change in the board of directors Director changes
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}
06-09-2017 Dirk Verbestel resigns as director Director changes
  • Dirk Verbestel, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "Bestuurder",
      "person": {
        "rrn": null,
        "name": "Dirk Verbestel",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}
2016
05-07-2016 Sofie Depuydt appointed as volmachtdrager / vertegenwoordiger Director changes
  • Sofie Depuydt, Volmachtdrager / vertegenwoordiger
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "volmachtdrager / vertegenwoordiger",
      "person": {
        "rrn": null,
        "name": "Sofie Depuydt",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}
2011
15-06-2011 2 directors appointed, 1 resigning Director changes
  • Luc Van Steenwinkel, Bestuurder
  • Luc Van Steenwinkel, Gedelegeerd bestuurder
  • J. Deneve, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "Bestuurder",
      "person": {
        "rrn": null,
        "name": "J. Deneve",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Bestuurder",
      "person": {
        "rrn": null,
        "name": "Luc Van Steenwinkel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Gedelegeerd Bestuurder",
      "person": {
        "rrn": null,
        "name": "Luc Van Steenwinkel",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium NV"
  }
}
28-01-2011 2 directors appointed, 1 resigning Director changes
  • P. Duffy, Bestuurder
  • P. Duffy, Voorzitter van de raad van bestuur
  • P. Ginestet, Voorzitter van de raad van bestuur
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "Voorzitter van de Raad van Bestuur",
      "person": {
        "rrn": null,
        "name": "P. Ginestet",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Bestuurder",
      "person": {
        "rrn": null,
        "name": "P. Duffy",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Voorzitter van de Raad van Bestuur",
      "person": {
        "rrn": null,
        "name": "P. Duffy",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium NV"
  }
}
2003
15-12-2003 3 directors appointed, 6 resigning Director changes
  • Karl Aymanns, Bestuurder
  • W. Van Effeltaire, Bestuurder
  • J. Deneve, Afgevaardigd bestuurder
  • Ö. Baysal, Bestuurder
  • G.G. Brouwers, Bestuurder
  • E. Catthoor, Bestuurder
  • P. De Backer, Bestuurder
  • C. De Waen, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "\u00D6. Baysal",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "G.G. Brouwers",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "E. Catthoor",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "P. De Backer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "C. De Waen",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "D. Rapic",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Karl Aymanns",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "W. Van Effeltaire",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "afgevaardigd bestuurder",
      "person": {
        "rrn": null,
        "name": "J. Deneve",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "Pfizer Manufacturing Belgium"
  }
}
19-06-2003 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0400.778.165",
    "name_full": "PHARMACIA"
  },
  "legal_form_change": {
    "new": "naamloze vennootschap",
    "old": "naamloze vennootschap",
    "changed": false
  }
}
Credit advice verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
Company registry (CBE) Crossroads Bank
Activities
Vervaardiging van geneesmiddelen21201Groothandel in farmaceutische en medische artikelen46460
Primary activity highlighted.
Names & trade names
Legal nameNL PFIZER MANUFACTURING BELGIUM
Registered office
Rijksweg 12
2870 Puurs-Sint-Amands, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same sector and region · no size comparison possible · 26 of 149 with filed accounts
Alcon Laboratories Belgium BE 0830.069.679 · Puurs-Sint-Amands
Novartis Manufacturing BE 0402.134.977 · Puurs-Sint-Amands
Purna Pharmaceuticals BE 0428.742.176 · Puurs-Sint-Amands
Advanced Practical Diagnostics BE 0806.556.285 · Turnhout
BelCoPhar BE 0789.518.434 · Kalmthout
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative